- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDTAE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 7 | SGX Company Announcements | ||
| TIANJIN PHARMACEUTICAL DA REN TANG Aktie jetzt für 0€ handeln | |||||
| 03.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON CONVENING AN ONLINE CONFERENCE | 2 | SGX Company Announcements | ||
| 29.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDTAE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | - | SGX Company Announcements | ||
| 25.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON THE EVALUATION REPORT ON THE 2024 ACTION PLAN AND ON THE 2025 ACTION PLAN | 1 | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::PROPOSED PURCHASE OF LIABILITY INSURANCE FOR THE COMPANY | - | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ANNOUNCEMENT ON CONTINUOUS RISK ASSESSMENT REPORT OF TPGF | - | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON THE DEPOSIT OF NET PROCEEDS AND THE USE OF NET PROCEEDS | - | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 5TH BOARD MEETING FOR FY2025 | - | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::SECOND QUARTER AND/OR HALF YEARLY RESULTS | 3 | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 1 | SGX Company Announcements | ||
| 13.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::CLOSURE OF TWO DESIGNATED ACCOUNTS FOR THE PROCEEDS FROM THE PLACEMENT | - | SGX Company Announcements | ||
| 14.07. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ESTIMATED RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025 | 2 | SGX Company Announcements | ||
| 03.07. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF THE 1ST EXTRAORDINARY GENERAL MEETING OF THE COMPANY FOR FY2025 HELD ON 9 JUNE 2025 | 2 | SGX Company Announcements | ||
| 27.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::COMPLETION OF THE PROPOSED DISPOSAL OF THE REMAINING 12% EQUITY INTEREST IN TSKF | 4 | SGX Company Announcements | ||
| 26.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::CASH DIVIDEND/DISTRIBUTION::MANDATORY | 1 | SGX Company Announcements | ||
| 20.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE PROPOSED ENTRY INTO A LEASE AGREEMENT AS AN INTERESTED PERSON TRANSACTION | - | SGX Company Announcements | ||
| 20.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE PROPOSED ENTRY INTO AN EQUITY CUSTODY AGREEMENT AS AN INTERESTED PERSON TRANSACTION | - | SGX Company Announcements | ||
| 20.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 4TH BOARD MEETING FOR FY2025 | - | SGX Company Announcements | ||
| 18.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CASH DIVIDEND/DISTRIBUTION::MANDATORY | 2 | SGX Company Announcements | ||
| 09.06. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 146,55 | -1,45 % | Signifikanter Erfolg für Krebsmittel von Astrazeneca und Daiichi Sankyo | DJ Signifikanter Erfolg für Krebsmittel von Astrazeneca und Daiichi Sankyo
Von Adam Whittaker
DOW JONES--Das Krebsmedikament Datroway von Astrazeneca und Daiichi Sankyo hat in einer klinischen... ► Artikel lesen | |
| TEVA | 17,200 | -0,29 % | Biotech: Kleine Innovationen, große Wirkung mit Teva Pharmaceutical, BioNxt, Lonza Group | Wer in Biotech investiert, der wünscht sich, das nächste große Ding im Depot zu haben: Wirkstoffe, die alles revolutionieren, Technologien, die den Unterschied machen. Tatsächlich gibt es in der Biotechnologie... ► Artikel lesen | |
| SINOPHARM | 2,020 | -0,30 % | SINOPHARM (01099): NOTICE OF BOARD MEETING | ||
| CSPC PHARMA | 1,022 | +0,49 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - SYH2070 INJECTION (A DOUBLE-STRANDED SMALL INTERFERING RNA DRUG) OBTAINS CLINICAL TRIAL APPROVAL IN THE ... | ||
| WUXI BIOLOGICS | 3,900 | -5,72 % | WuXi Biologics-Aktie leicht im Plus (4,441 €) | Das Wertpapier von WuXi Biologics notiert heute fester. Das Papier kostete zuletzt 4,44 Euro. Ein Preisanstieg in Höhe von 17 Cent erfreut derzeit die Aktionäre von WuXi Biologics. Zur Stunde kostet... ► Artikel lesen | |
| OPKO HEALTH | 1,300 | -0,37 % | OPKO Health, Inc.: OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting | MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) ("Entera") today announced that new pharmacologic and pharmacokinetic in vivo... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 2,708 | +2,19 % | Ex-Fosun Pharma Chief Takes Helm at Cancer Jab Developer Everest Medicines | ||
| GEDEON RICHTER | 26,320 | 0,00 % | Gedeon Richter Plc.: 2025 Half-yearly Report | ||
| DR REDDYS | 12,300 | +1,65 % | Esperion Therapeutics, Inc.: Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy's Laboratories, Not to Market Generic Versions of NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) Prior ... | ANN ARBOR, Mich., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Dr. Reddy's Laboratories, Inc. and its affiliate Dr.... ► Artikel lesen | |
| THC BIOMED | 0,011 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.09.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 23.09.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.09.2025.ISIN NameAU0000221251 LEO... ► Artikel lesen | |
| BAYER | 27,980 | -0,78 % | DAX fest, Gold, Bitcoin, Nikkei mit Rekorden: Redcare, Nordex, Merck, Siemens Energy, Bayer ... | Der DAX hat sich am Freitag nach einer starken Woche bei 24.378,80 Punkten ins Wochenende verabschiedet. Auf Wochensicht konnte er 2,7 Prozent zulegen. Zum Start in die neue Woche dürfte es noch ein... ► Artikel lesen | |
| MERCK KGAA | 116,10 | -1,74 % | Unilever Appoints Merck CEO Belén Garijo López as Independent Non-Executive Director | ||
| NOVO NORDISK | 49,510 | -2,39 % | Trader-Interview mit Rene Berteit: Rheinmetall, Novo Nordisk, Nvidia, Tesla & Siemens AG | In dieser Ausgabe des Trader-Interviews sprechen Andreas Bernstein und Rene Berteit über spannende Chancen bei .. ► Artikel lesen | |
| METSERA | 52,85 | +0,48 % | Metsera, Inc.: Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3 | Placebo-subtracted mean weight loss up to 14.1% after 28 weeks with no plateau Potential for best-in-class tolerability with minimal diarrhea signal, 13% nausea, and 11% vomiting High study and... ► Artikel lesen | |
| GSK | 18,700 | -1,14 % | GSK stellt auf dem Gartner Supply Chain Planning Summit seine beschleunigte IBP-Transformation mit OMP vor | ANTWERPEN, BE / ACCESS Newswire /
9. Oktober 2025 / OMP, ein führender Anbieter von Lösungen für die Lieferkettenplanung, stellt auf dem Gartner Supply Chain Planning Summit 2025 in London vor... ► Artikel lesen |
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 2,423 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD finden Sie auf Wallstreet Online.